Rockwell Medical, Inc. IPO Research Information

Rockwell Medical, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Rockwell Medical, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Rockwell Medical, Inc.	RMTI -	Last trade $2.78	$2.35	$0.00	3.2 million ADSs	2/4/2020
Underwriter(s): Cantor Fitzgerald
Co-Manager(s):
Industry:
Filing(s):

Rockwell Medical, Inc. Quote & Chart - Click for current quote - RMTI

About Rockwell Medical, Inc. (adapted from Rockwell Medical, Inc. prospectus):
Rockwell Medical is a biopharmaceutical company dedicated to improving outcomes for patients with anemia, with an initial focus on end-stage renal disease (ESRD) and chronic kidney disease (CKD).

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "RMTI" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.